Quantum-Enhanced Predictive Genomics Market Report 2026

Quantum-Enhanced Predictive Genomics Market Overview

• Quantum-Enhanced Predictive Genomics market size has reached to $1.95 billion in 2025 • Expected to grow to $8.36 billion in 2030 at a compound annual growth rate (CAGR) of 33.7% • Growth Driver: Surge In Demand For Personalized Medicine Fueling The Growth Of The Market Due To Improved Treatment Effectiveness • Market Trend: Norma And Snubh Collaborate To Apply Quantum Algorithms In Genomics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Quantum-Enhanced Predictive Genomics Market?

Quantum-enhanced predictive genomics is the use of quantum computing to analyze complex genomic data, enabling faster and more accurate predictions of disease risk, treatment response, and other health outcomes. It uncovers patterns in large-scale genetic datasets that classical methods may miss, supporting biomarker discovery and personalized medicine. The main technologies of quantum-enhanced predictive genomics include quantum computing, quantum machine learning, quantum cryptography, and others. Quantum Computing refers to advanced computational platforms designed for rapid analysis and interpretation of complex genomic datasets. There are deployment modes such as cloud-based and on-premises. These solutions can be deployed in cloud-based or on-premises environments, catering to key end users including pharmaceutical and biotechnology companies, research institutes, healthcare providers, and other organizations involved in genomics and precision medicine.

What Is The Quantum-Enhanced Predictive Genomics Market Growth Forecast?

The quantum-enhanced predictive genomics market size is expected to see exponential growth in the next few years. It will grow to $8.36 billion in 2030 at a compound annual growth rate (CAGR) of 33.7%. The growth in the forecast period can be attributed to increasing availability of commercial quantum computing platforms, rising investment in precision medicine research, growing demand for predictive healthcare analytics, expansion of quantum machine learning applications, increasing collaboration between genomics and quantum technology firms. Major trends in the forecast period include increasing adoption of quantum-based genomic modeling, rising use of hybrid quantum-classical analytics, growing focus on high-dimensional biomarker discovery, expansion of cloud-based quantum genomics platforms, enhanced emphasis on predictive disease risk modeling.

Global Quantum-Enhanced Predictive Genomics Market Segmentation

1) By Technology: Quantum Computing, Quantum Machine Learning, Quantum Cryptography, Other Technologies 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Disease Risk Assessment, Drug Discovery, Personalized Medicine, Genomic Data Analysis, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Healthcare Providers, Other End-Users Subsegments: 1) By Quantum Computing: Gate Based Quantum Computing, Quantum Annealing, Topological Quantum Computing, Photonic Quantum Computing 2) By Quantum Machine Learning: Supervised Learning, Unsupervised Learning, Reinforcement Learning, Deep Learning 3) By Quantum Cryptography: Quantum Key Distribution, Quantum Random Number Generation, Quantum Secure Communication, Post Quantum Cryptography 4) By Other Technologies: Quantum Sensors, Quantum Simulation, Quantum Networking, Hybrid Quantum Classical Systems

What Is The Driver Of The Quantum-Enhanced Predictive Genomics Market?

The growing demand for personalized medicine is expected to propel the growth of the quantum-enhanced predictive genomics market going forward. Personalized medicine refers to tailoring medical care, treatments, and prevention strategies to an individual’s unique genetic, biological, and clinical profile. The rise in demand for personalized medicine is due to improved treatment effectiveness, as therapies tailored to an individual’s genetic profile have led to better outcomes and fewer adverse effects. Quantum-enhanced predictive genomics supports personalized medicine by enabling ultra-fast analysis of complex genomic data, allowing clinicians to design highly precise, individualized treatment and prevention strategies. For instance, in 2024, according to NHS England, a UK-based public health system, the NHS genomic medicine service delivered over 810,000 personalized genomic tests for patients, an 8% increase from 2023, demonstrating rising clinical demand for genomic-led care. Therefore, the growing demand for personalized medicine is expected to drive the growth of the quantum-enhanced predictive genomics industry.

Key Players In The Global Quantum-Enhanced Predictive Genomics Market

Major companies operating in the quantum-enhanced predictive genomics market are Google LLC, Microsoft Corporation, Alibaba Group Holding Limited, Amazon Web Services, Inc., F. Hoffmann-La Roche AG, Accenture plc, IBM Corporation, Honeywell International Inc., Fujitsu Limited, Eviden, Xanadu Quantum Technologies Inc., Pasqal SA, Rigetti Computing, Inc., IonQ, Inc., D-Wave Systems Inc., Quantinuum, Atom Computing, Inc., Alice & Bob, QC Ware Corp., PsiQuantum, Inc., QuEra Computing, Inc., Quandela, Quantum Motion Ltd., Amazon.com, Inc., Intel Corporation, Cambridge Quantum Computing Ltd., Atos SE, NEC Corporation

Global Quantum-Enhanced Predictive Genomics Market Trends and Insights

Major companies in the quantum-enhanced predictive genomics market are focusing on innovations such as high-throughput genomic data processing to accelerate the identification of genetic variations, improve predictive accuracy in personalized medicine, and enable faster, more precise analysis of complex genomic datasets. High-throughput genomic data processing refers to the rapid, large-scale analysis of genomic sequences using advanced computational methods. For instance, in June 2025, Norma Group, a Germany-based developer and manufacturer of engineered and standardized joining and fluid-handling technology, partnered with Seoul National University Bundang Hospital (SNUBH) to apply quantum algorithms to large-scale genomic analysis. The project aims to accelerate the detection of genetic mutations through quantum-enhanced combinatorial optimization, improving both the speed and accuracy of genomic data processing beyond classical computing methods. Key applications include precision diagnostics, personalized treatment planning, and genetic risk assessment for diseases such as cancer and neurological disorders.

What Are Latest Mergers And Acquisitions In The Quantum-Enhanced Predictive Genomics Market?

In August 2025, Quantinuum, a UK-based software firm, partnered with the Wellcome Sanger Institute to advance quantum computing applications in genomics. The collaboration is part of the Sanger Institute’s Wellcome Leap Quantum for Bio (Q4Bio) challenge, a global initiative supporting research in quantum-based genomic analysis. Sanger Institute is a UK-based institute developing quantum-enhanced predictive genomics.

Regional Outlook

North America was the largest region in the quantum-enhanced predictive genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quantum-Enhanced Predictive Genomics Market?

The quantum-enhanced predictive genomics market consists of revenues earned by entities by providing services such as clinical decision support services, oncology-focused predictive genomics services, and multi-omics integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantum-enhanced predictive genomics market includes sales of quantum-powered epigenetic predictive tools, quantum-integrated personalized preventive health tools, and quantum-enhanced synthetic biology design platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quantum-Enhanced Predictive Genomics Market Report 2026?

The quantum-enhanced predictive genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quantum-enhanced predictive genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.